RESTRICTED
COMITE PREPARATOIRE DE G/RS/25
L'ORGANISATION MONDIALE 15décembre 1994
DUCOMMERCE
(94-2795)
Original: anglais
RECTIFICATIONS ETMODIFICATIONS DELISTES
ANNEXEES AUPROTOCOLE DEMARRAKECH
Liste V-Canada
LaMission permanente duCanada afaitparvenir ausecrétariat lacommunication ci-après,
endatedu7décembre 1994.
_______________
Vous trouverez ci-joint uncorrigendum technique1concernant laListe V-Canada, quise
rapporte àl'arrangement visant àéliminer lesdroits surlesproduits pharmaceutiques. Cecorrigendum
nemodifie paslesengagements NPFduCanada.
_______________
Siaucune objection n'estnotifiée ausecrétariat dansundélaide30jours àcompter deladate
duprésent document, lesrectifications apportées àlaListe V-Canada seront considérées comme
approuvées etferont l'objet d'unprocès-verbal officiel.
1Enanglais seulement.G/RS/25
Page2
CORRIGENDUM TOSCHEDULE V-CANADA
ANNEX D-PHARMACEUTICAL PRODUCTS
(English Version)
Canada issubmitting thefollowing changes totheEnglish version ofSchedule V,Annex D.Most
ofthese changes aretechnical innature while others reflect corrections already agreed bythe
Contracting Parties. Thechanges donotalterCanada 'scommitment toeliminate duties onanyof
thepharmaceuical products specified initsschedule which wasattached totheMarrakesh
Protocol.
ANNEX I:
1. Thefollowing lineisdeleted:
290611 2216-51-5 levomenthol
2. Thefollowing INNs were listed twice inAnnex IwithtwoCAS numbers. Theduplicates
withtheincorrect CAS RNareremoved asfollows:
291570 555-44-2 tripalmitin
292250 407-41-0 dexfosfoserine
292250 96346-61-1 onapristone
293090 5667-98-1 aldesulfone sodium
293390 84812-85-1 tazadolene
293410 68247-85-8 peplomycin
293490 100599-27-7 tenidap
3. Thewords "excluding monosodium glutamate" should beinserted after"glutamic acid
(INN)" asfollows:
292242 56-86-0 glutamic acid(INN) excluding monosodium glutamate
4. Thefollowing (ISO) abbreviations arereplaced bytheappropriate (INN):
291430 82-66-6 diphenadione (INN) replaces diphacinone (ISO)
291900 470-90-6 clofenvinfos (INN) replaces chlorfenvinphos (ISO)
292010 2104-96-3 bromofos (INN) replaces bromophos (ISO)
292010 299-84-3 fenclofos (INN) replaces fenchlorphos (ISO)
292429 63-25-2 carbaril (INN) replaces carbaryl (ISO)
293090 786-19-6 carbofenotion (INN) replaces carbophenothion (ISO)
293090 3383-96-8 temefos (INN) replaces temephos (ISO)
293100 52-68-6 metrifonate (INN) replaces trichlorfon (ISO)
293229 56-72-4 coumafos (INN) replaces coumaphos (ISO)
293290 78-34-2 dioxation (INN) replaces dioxathion (ISO)
293359 333-41-5 dimpylate (INN) replaces diazinon (ISO)
293410 148-79-8 tiabendazole (INN) replaces thiabendazole (ISO)G/RS/25
Page3
5. Thefollowing spelling corrections aremade inaccordance withL/7430/Add.4 of
August 3,1994:
292229 1518-86-1 hydroxyamfetamine replaces hydroxyamphetamine
292250 85750-39-6 etilefrine pivalate replaces etilefrine privalate
293490 118812-69-4 ularitide replaces ulartitude
ANNEX II:
1. "SODIUM" isadded tothelistfollowing "SALICYLOYLACETATE" inaccordance with
L/7430/Add.4 of3August 1994.
2. "(PIVALOYLOXY)METHYL HYDROCHLORIDE" isadded tothelistfollowing
"(PIVALOYLOXY)METHYL" astheformer isasynonym for"PIVOXIL HYDROCHLORIDE"
which isalready listed inAnnex II.
3. Thefollowing WHO radicals orgroups which were previously missing from Annex IIare
eachadded tothelistinalphabetical order:
ACETURATE DEANIL METEMBONATE
ACISTRATE DECIL MOFETIL
ACOXIL DIBUDINATE OCTIL
AMSONATE DIBUNATE OLAMINE
BEZOMIL DIGOLIL OXOGLURATE
BUCICLATE DIOLAMINE PIVOXETIL
BUNAPSILATE DOCOSIL PROXETIL
BUTEPRATE DOFOSFATE STEAGLATE
CARBESILATE ERBUMINE TENOATE
CICLOTATE ETABONATE TEPROSILATE
CIPIONATE FARNESIL TOFESILATE
CLOSILATE FENDIZOATE TRICLOFENATE
CROBEFATE HIBENZATE TRIFLUTATE
CROMACATE HYCLATE TROLAMINE
CROMESILATE LAURILSULFATE TROXUNDATE
DAPROPATE MEGALLATE XINAFOATE
4. Thefollowing items arereplaced tocorrect spelling ortomake minor modifications such
astheaddition ordeletion ofspaces:
ALLYLBROMIDE replaces ALLYL BROMIDE
ALLYLIODIDE replaces ALLYL IODIDE
BENZYLBROMIDE replaces BENZYL BROMIDE
BENZYLIODIDE replaces BENZYL IODIDE
BIS(HYDROGEN MALATE) replaces BIS(HYDROGEN) MALATE
BIS(HYDROGEN MALEATE) replaces BIS(HYDROGEN) MALEATE
BIS(HYDROGEN MALONATE) replaces BIS(HYDROGEN) MALONATE
CAMPHOR-10-SULPHONATE replaces CAMPHOR-10-SUPHONATE
CYCLOHEXANEPROPIONATE replaces CYCLOHEXANPROPIONATEG/RS/25
Page4
ETHYLIODIDE replaces ETHYL IODIDE
1,5-NAPHTHALENEDISULFONATE replaces 1,5-NAPHTHALENESULFONATE
PROPIONATEDODECYL SULPHATE replaces PROPIONATE DODECYL
SULPHATE
SODIUM HYDROGEN PHOSPHATE replaces SODIUM HYDROGEN
PHOSPHATESODIUM
SODIUM METHANESULPHONATE replaces METHANESULPHONATE
SUCCINYL replaces SUCCINIL
5. Thefollowing arere-arranged inthealphabetical listing asthe"N"should notbetaken
intoaccount forthealphabetical order:
N-CYCLOHEXYLSULPHAMATE ismoved tofollow CYCLOHEXYLPROPIONATE
N-OXIDE HYDROCHLORIDE ismoved tofollow OXIDE
6. Thefollowing aredeleted from thelistastheyareduplicates andtriplicates withminor
spelling variations:
BESYLATE ISETHIONATE
tert-BUTYL ACETATE MESYLATE
tertiary BUTYL ACETATE METHYLSULFATE
tert-BUTYL ESTER METHYLSUPHATE
tertiary BUTYL ESTER NAPADISYLATE
CAMSYLATE NAPSYLATE
DECANOATE THEOCLATE
ENANTHATE
ESYLATE
ANNEX III:
1. Thefollowing items aredeleted:
2907.29 DIETHYLSTILBESTROL DIETHYLSTILBESTROL DIFUROATE 2932.19
549-40-6
Thisitemcorresponds toFurostilbestrol (INN) which isalready included inAnnex I.
2933.39 HALOPERIDOL HALOPERIDOL DECANOATE 2933.90 74050-97-8
Asthecorrect HSclassification ofHALOPERIDOL DECANOATE is2933.39, itisinthe
same subheading astheactive ingredient anddoesneedtobelisted inAnnex III.
2934.30 PROMETHAZINE PROMETHAZINE TEOCLATE 2939.50 17693-51-5
PROMETHAZINE TEOCLATE isanINNinitsownrightandisalready included in
Annex I.
2. Thefollowing items arereplaced tocorrect spelling orfortheaddition ofspaces in
accordance withL/7430/Add.4 of3August 1994:G/RS/25
Page5
2909.49 CHLORPHENESIN CHLORPHENESIN CARBAMATE 2924.29
886-74-8
replaces
2909.49 CHORPHENESIN CHORPHENESIN CARBAMATE 2924.29
886-74-8
2918.90 ENOXOLONE ENOXOLONE DIHYDROGEN PHOSPHATE 2919.00 18416-35-8
replaces
2918.90 ENOXOLONE ENOXOLONE DIHYDROGENPHOSPHATE 2919.00 18416-35-8
3. Thefollowing corrections ofCAS RNaremade inaccordance withL/7430/Add.4
of3August 1994:
CAS RN742-92-2 isreplaced by74203-92-2; and
CAS RN13931-76 isreplaced by13931-75-4
ANNEX IV:
1. Thefollowing areamended toreflect theproper HSsubheading:
2918.50 30131-16-9 4-(Phenylbutoxy) benzoic acid
becomes
2918.90 30131-16-9 4-(Phenylbutoxy) benzoic acid
2922.19 120-20-7 2-(3,4-Dimethoxyphenyl)ethylamine
becomes
2922.29 120-20-7 2-(3,4-Dimethoxyphenyl)ethylamine
2922.50 55174-61-3 Benzene-ethanamine-3,4-dimethoxy-betamethyl
becomes
2922.29 55174-61-3 Benzene-ethanamine-3,4-dimethoxy-betamethyl
2932.29 24155-42-8 alpha-(2,4-Dichlorophenyl)-1H-imidazole-1-ethanol
becomes
2933.29 24155-42-8 alpha-(2,4-Dichlorophenyl)-1H-imidazole-1-ethanol
2932.59 298-81-7 8-Methoxypsoralen
becomes
2932.29 298-81-7 8-Methoxypsoralen
2932.90 37743-18-3 N-[Dihydro-3,3-diphenyl-2(3H)-furanylidene]-N-
methylmethanaminium bromide
becomes
2932.19 37743-18-3 N-[Dihydro-3,3-diphenyl-2(3H)-furanylidene]-N-
methylmethanaminium bromide
2933.29 103094-30-0 3-Ethyl-5-methyl-4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1.3-
dihydro-1,3-dioxo-2H-isoindol-2-yl) ethoxy (methyl)-6-methyl-
3,5-pyridine dicarboxylate
becomesG/RS/25
Page6
2933.39 103094-30-0 3-Ethyl-5-methyl-4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1.3-
dihydro-1,3-dioxo-2H-isoindol-2-yl) ethoxy (methyl)-6-methyl-
3,5-pyridine dicarboxylate
2933.39 83857-96-9 1H-Imidazole-4-carboxaldehyde, 2-butyl-5-chloro-
becomes
2933.29 83857-96-9 1H-Imidazole-4-carboxaldehyde, 2-butyl-5-chloro-
2933.40 7597-60-6 1,3-Dimethyl-4-amino-5-formylaminouracil
becomes
2933.59 7597-60-6 1,3-Dimethyl-4-amino-5-formylaminouracil
2933.90 57988-58-6 4-(4-Bromophenyl)-4-piperidinol
becomes
2933.39 57988-58-6 4-(4-Bromophenyl)-4-piperidinol
2934.90 9585-13-5 5-Ethyl-4-(2-phenoxyethyl)-2H-1,2,4-triazol-3(4H)-one
becomes
2933.90 9585-13-5 5-Ethyl-4-(2-phenoxyethyl)-2H-1,2,4-triazol-3(4H)-one
2934.90 114873-37-9 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid
becomes
2933.90 114873-37-9 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid
2934.90 66242-82-8 2,5-Dihydro-5-thioxo-1H-tetrazole-1-methanesulphonic acid,
disodium salt
becomes
2933.90 66242-82-8 2,5-Dihydro-5-thioxo-1H-tetrazole-1-methanesulphonic acid,
disodium salt
2. Asthefollowing items correspond toINNs included inAnnex I,theyaredeleted from
Annex IV:
2924.29 29122-68-7 2-[4-(2-Hydroxy-3-isopropyl aminopropoxy)phenyl] acetamide
corresponds toatenolol (INN)
2932.19 66357-35-5 N-[2-((5-((Dimethylamino)methyl)-2-furanylmethyl)thio)-ethyl]-
N-methyl-2-nitro-1,1-ethenediamine
corresponds toranitidine (INN)
2933.39 115-46-8 alpha,alpha-Diphenyl-4-piperidinemethanol hydrochloride
corresponds toazacyclonol (INN)
2933.59 98079-51-7 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-
oxoquinoline-3-carboxylic acid
corresponds tolomefloxacin (INN)
2933.79 105431-72-9 2H-Indol-2-one, 1,3-dihydro-1-phenyl-3,3-bis (4-
pyridinylmethyl)
corresponds tolinopirdine (INN)G/RS/25
Page7
2933.90 91441-48-4 Anthra[1,9-cd] pyrazol-6(2H)-one,7,10-dihydroxy-2 (2-[(2-
hydroxyethyl)amino]ethyl)-5-[(2-(methylamino)ethyl)amino]
corresponds toteloxantrone (INN)
2934.90 53910-25-1 (R)-3-(2-Deoxy-beta-D-erythropentofuranosyl)-3,4,7,8-
tetrahydo-imidazo-(4,5)(1,3)diazepin-8-ol
corresponds topentostatin (INN)
2934.90 69655-05-6 2',3'-Dideoxyinosine
corresponds todidanosine (INN)
2934.90 3056-17-5 3'-Deoxy-2 ',3'-didehydrothymidine
corresponds tostavudine (INN)
3. TheCAS Noindicated below replaces thedesignation "NA" onthefollowing items:
2926.90 151338-11-3 3-Cyana-N-(1,1-dimethylethyl)-androsta-3,5-diene-17 beta-
carboxamide
2931.00 123599-78-0 [(2-Methyl-1)-1-oxyl propoxy)(propoxy)-(4-phenylbutyl 1)-
phosphinyl] acetate